We recently published a list of 10 Best Stocks to Buy According to Billionaire David Einhorn. In this article, we are going ...

AstraZeneca signed a deal with Alteogen worth up to $1.35 billion for subcutaneous cancer drugs. Taiho Pharmacetical bought ...

Alnylam's Amvuttra enters ATTR-CM drug race, and Expedition Therapeutics seeks to bring Chinese drugs to the U.S.

Immunovant stock opened at $19.64 on Thursday. Immunovant has a 1 year low of $17.01 and a 1 year high of $34.47. The firm has a 50 day moving average price of $20.86 and a 200 day moving average ...

In this article, we are going to take a look at where Roivant Sciences Ltd. (NASDAQ:ROIV) stands against other best stocks to buy according to billionaire David Einhorn. David Einhorn is a highly ...

We recently published a list of 10 Best Stocks to Buy According to Billionaire David Einhorn. In this article, we are going to take a look at where Roivant Sciences Ltd. (NASDAQ:ROIV) stands against ...

Shares of NASDAQ IMVT opened at $19.64 on Thursday. The company has a market cap of $3.34 billion, a P/E ratio of -7.50 and a beta of 0.68. Immunovant has a 1 year low of $17.01 and a 1 year high ...

Trial results will inform potential marketing approval application in non-small cell lung cancer, one of the largest indications in oncology SYDNEY, AUSTRALIA, March 25, 2025 (GLOBE NEWSWIRE ...